跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
魏 淳郁
助理研究員
,
個人化疫苗暨腫瘤新抗原分析核心實驗室
https://orcid.org/0009-0002-1664-3396
電子郵件
weinancy
tmu.edu
tw
h-index
3532
引文
15
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2005
2025
每年研究成果
概覽
指紋
網路
專案
(2)
研究成果
(26)
類似的個人檔案
(6)
指紋
查看啟用 Chun-Yu Wei 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
Allele
7%
Autosomal Recessive Disorder
15%
Azathioprine
7%
Cell Proliferation
15%
Cytotoxicity
7%
Disease Burden
15%
Drug Metabolism
15%
Drug Response
15%
Electronic Medical Record
13%
Erethism
25%
Genetic Association
7%
Genetic Determinism
23%
Genetic Divergence
44%
Genetic Risk
29%
Genetic Screening
15%
Genetic Susceptibility
15%
Genetic Variation
31%
Genetics
100%
Genome-Wide Association Study
28%
Genomics
46%
Genotyping
17%
Herpesviridae
11%
HLA-B
15%
HLA-C
11%
HLA-DQB1
15%
HLA-DRB1
7%
Homozygosity
15%
Human Genetics
15%
Human Genome
15%
Immunogenicity
15%
Kidney Function
15%
Macrophage Migration
15%
Major Histocompatibility Complex
11%
Mediator
15%
Mitogen-Activated Protein Kinase
7%
Normal Human
7%
Polygenic Score
42%
Principal Component Analysis
15%
Protein Kinase B
7%
Single Nucleotide Polymorphism
15%
Single-Nucleotide Polymorphism
27%
SLCO1B1
7%
SNP Array
15%
T Cell
7%
T Cell Receptor
15%
Transcriptomics
20%
Tumor Necrosis Factor
7%
Virus Entry
11%
VKORC1
15%
Whole Genome Sequencing
15%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Generalized Exanthematous Pustulosis
5%
Adverse Drug Reaction
33%
Adverse Event
11%
Alternative Complement Pathway C3 C5 Convertase
15%
Anticonvulsive Agent
17%
Biological Marker
6%
Blister
10%
Carbamazepine
50%
Cytotoxicity
9%
Diseases
8%
Drug Intolerance
8%
Fibrosis
15%
Fixed Drug Eruption
5%
Granulysin
17%
Herpesvirus Entry Mediator
15%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
15%
Inducible Nitric Oxide Synthase
15%
Interleukin 1
15%
Leukocyte Antigen
7%
Lipopolysaccharide
15%
Liver Fibrosis
15%
Nitric Oxide Synthase
9%
Nuclear Factor
15%
Pharmaceutics
15%
Pharmacogenetics
15%
Pharmacogenomics
15%
Rho Kinase
15%
Stevens Johnson Syndrome
47%
Syndrome
13%
T Lymphocyte Receptor
15%
Toxic Epidermal Necrolysis
56%
Toxicity
15%
Immunology and Microbiology
Allele
15%
Blister Fluid
7%
Cell Proliferation
15%
Cytotoxic T Cell
20%
Cytotoxicity
9%
DRESS Syndrome
7%
Drug Hypersensitivity
34%
Genetic Susceptibility
15%
Genetic Variation
15%
Granulysin
17%
Herpesviridae
9%
HLA DQA1 Antigen
7%
HLA DQB1 Antigen
15%
HLA DRB1 Antigen
7%
Keratinocyte
15%
Kidney Function
15%
Macrophage Migration
15%
Major Histocompatibility Complex
5%
Mediator
28%
Normal Human
6%
Peptides
12%
Single Nucleotide Polymorphism
11%
Stevens Johnson Syndrome
77%
T Cell
20%
T Cell Receptor
15%
Vascular Smooth Muscle Cell
15%
Viral Entry
9%
